| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10225585 | Schizophrenia Research | 2018 | 7 Pages |
Abstract
Clozapine use was associated with very high rates of cardiovascular and metabolic risk factors, which were frequently under-treated. Management of both physical and mental health should be prioritized. Polypharmacy should be rationalized. Future research should investigate the effectiveness of smoking cessation and lifestyle interventions in this high-risk population.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Julia Margaret Lappin, Marlene Wijaya, Andrew Watkins, Rachel Morell, Scott Teasdale, Oscar Lederman, Simon Rosenbaum, Stephanie Dick, Philip Ward, Jackie Curtis,